MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Non-Progressive Coreoatethosis Secondary to Infantile Necrotizing Encephalopathy Mimicking Leigh Disease.

    G. Fabiani, H. Teive (Curitiba, Brazil)

    Objective: Our objective is to report  image findings of an acute necrotizing encephalopathy of childhood (ANEC) in a 15 years-old girl, completely normal until 18…
  • 2017 International Congress

    Using eye tracking to identify pupil and saccade biomarkers of neurodegenerative disease

    D. Munoz, B. Coe, J. Huang, M. Smorenburg, D. Brien, S. Black, M. Borrie, D. Dowlatshahi, E. Finger, D. Grimes, M. Freedman, A. Lang, C. Marras, M. Masellis, R. Swartz, C. Tartaglia, L. Zinman, t. ONDRI Investigators (Kingston, ON, Canada)

    Objective: The Ontario Neurodegeneration Research Initiative Program (1) is investigating patients with neurodegeneration (Alzheimer’s disease: AD; mild cognitive impairment: MCI; Parkinson’s disease: PD; amyotrophic lateral…
  • 2017 International Congress

    Reappraisal of Progressive Myoclonus Ataxia

    S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To define the clinical, electrophysiological and etiological features of progressive myoclonus ataxia (PMA). Background: PMA, formerly known as the Ramsay Hunt syndrome, is a…
  • 2017 International Congress

    PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins

    A. Perez-Soriano, J. Arena, V. Sossi, K. Dinelle, Q. Miao, J. McKenzie, N. Neilson, A. Puschmann, P. Schaffer, H. Shinotoh, J. Smith-Forrester, E. Shahinfard, N. Vafai, D. Wile, Z. Wszolek, M. Higuchi, A.J. Stoessl (Vancouver, BC, Canada)

    Objective: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 ([11C]methylamino pyridin-3-yl buta-1,3-dienyl benzo[d]thiazol-6-ol) in tauopathies, and in conditions not…
  • 2017 International Congress

    Using cognitive computing to identify compounds with antidyskinetic potential for Parkinson’s disease

    N. Visanji, A. Lacoste, S. Ezell, S. Spangler, E. Argentinis, J. Brotchie, A. Lang, T. Johnston (Toronto, ON, Canada)

    Objective: IBM Watson for Drug Discovery (WDD) is a platform that analyzes vast quantities of scientific data to help researchers identify hidden connections and formulate…
  • 2017 International Congress

    Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity

    I. Miyazaki, S. Murakami, R. Kikuoka, N. Isooka, Y. Kitamura, M. Asanuma (Okayama, Japan)

    Objective: In this study, we examined involvement of astrocytes in rotenone-induced dopaminergic neurotoxicity using primary cultured cells. Background: Several studies reported that pesticide exposure, such…
  • 2017 International Congress

    Tau predicts cognitive impairment in a prospective longitudinal CSF study in Parkinson’s Disease

    S. Lerche, I. Wurster, O. Hanson, B. Roeben, C. Schulte, T. Gasser, H. Zetterberg, D. Berg, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: We hypothesize that CSF profiles of Aβ and Tau (total and phosphorylated) are associated with clinical subtypes and disease progression. Background: Parkinson’s disease (PD)…
  • 2017 International Congress

    The Cats & Dogs Test: a web-based platform to detect early visual processing deficits in Parkinson’s disease

    R. Weil, B. Bahrami, D. Schwarzkopf, I. Pavisic, K. Pappa, R. Schade, H. Morris (London, United Kingdom)

    Objective: To develop a sensitive web-based test to detect visuo-perceptual deficits in patients with Parkinson’s disease as an early marker of dementia. Background: Up to…
  • 2017 International Congress

    Variation in Longevity Gene KLOTHO Associates with Measures of Resilience Against Parkinson’s Disease

    N. Luthra, J. Ostrem, D. Dubal (San Francisco, CA, USA)

    Objective: We investigated whether carrying one copy of the protective haplotype “KL-VS” of the longevity gene KLOTHO is associated with better cognitive functioning and/or attenuated…
  • 2017 International Congress

    Event-related potentials and mild cognitive impairment in Parkinson’s disease.

    J. Pagonabarraga, J. Marin-Lahoz, A. Horta, M. Cornella, H. Bejr-Kasem, S. Martinez-Horta, J. Pérez-Pérez, M.Á. Boti, J. Kulisevsky (Barcelona, Spain)

    Objective: To measure N170, P3a/P3b peak amplitudes and latencies in PD with (PD-MCI) and without (PD-NC) mild cognitive impairment and to correlate them with clinical-demographic, neuropsychological and…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley